• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library
    Biotech

    Zydus` Keytruda Biosimilar Succeeds in FYB206 Trial

    INDPHARMAPOST

    Zydus Lifesciences launches Anyra, biosimilar of Aflibercept 2 mg

    EXPRESSPHARMA

    SC Clears Zydus to Sell Cancer Drug; BMS Told to Map Patents

    ECONOMICTIMES

    Bristol Myers Halts Zydus` Biosimilar Cancer Drug Sales

    ECONOMICTIMES

    Zydus Lifesciences Introduces First Nivolumab Biosimilar

    ECONOMICTIMES

    Zydus Launches Biosimilar For Treatment Of Multiple Cancers

    ECONOMICTIMES

    Zydus Lifesciences Completes the Acquisition of Agenus Facility

    PR NEWSWIRE

    Zydus & Bioeq Partner for US NUFYMCO Launch

    PR NEWSWIRE

    Zydus Introduces Cost-Effective Biosimilar `Zyrifa`

    INDPHARMAPOST

    Zydus, Formycon Partner For Exclusive Biosimilar Supply

    PR NEWSWIRE

    SEC Seek Zydus` Revised Protocol For Ph 1 Chikungunya Vaccine

    PHARMABIZ

    Zydus launches VaxiFlu vaccine for flu protection

    INDPHARMAPOST

    Zydus Lifesciences Hosts Health Symposium on New WHO Guideline

    EXPRESSPHARMA

    Delhi HC Denies Zydus Plea to Withhold Sigrima Process

    PHARMABIZ

    Zydus Life`s Plans for Cancer Biosimilar Hit a Legal Hurdle

    ECONOMICTIMES

    Zydus Partners with Agenus for Cancer Therapies in India

    BUSINESSWIRE

    Zydus to acquire Agenus` U.S. facilities for biologics CDMO

    PR NEWSWIRE

    Zydus developing single pen for adjustable Semaglutide doses

    ECONOMICTIMES

    Zynext Ventures invests in Feldan Therapeutics for drug delivery

    PR NEWSWIRE

    Zydus, Gates Foundation To Develop Shigellosis-Typhoid Vaccine

    INDPHARMAPOST

    Zydus to launch protection against new strain of influenza virus

    INDPHARMAPOST

    Zydus Lifesciences inks licensing Pact with Zhuhai for Cancer

    ECONOMICTIMES

    Sterling & Zydus agree to extend completion of business transfer

    BUSINESS STD

    Zydus gets WHO nod for its typhoid vaccine

    ECONOMICTIMES

    Zydus To Acquire 50% Stake In Sterling Biotech From Perfect Day

    ECONOMICTIMES

    Zydus and Dr. Reddy`s announce agreement for marketing of Pertuzumab biosimilar

    PRESS RELEASE

    SEC recommends approval for Zydus Lifesciences` trivalent influenza vaccine

    PHARMABIZ

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.